These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29072254)

  • 21. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
    Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
    Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute coronary syndromes: Silent myocardial infarction increases the risk of heart failure.
    Lim GB
    Nat Rev Cardiol; 2018 Mar; 15(3):136. PubMed ID: 29368702
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.
    Ray KK; Ditmarsch M; Kallend D; Niesor EJ; Suchankova G; Upmanyu R; Anzures-Cabrera J; Lehnert V; Pauly-Evers M; Holme I; Štásek J; van Hessen MW; Jones P;
    Eur Heart J; 2014 Jul; 35(27):1792-800. PubMed ID: 24639426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction.
    Gibson CM; Korjian S; Tricoci P; Daaboul Y; Alexander JH; Steg PG; Lincoff AM; Kastelein JJ; Mehran R; D'Andrea D; Merkely B; Zarebinski M; Ophius TO; Harrington RA
    Am Heart J; 2016 Oct; 180():22-8. PubMed ID: 27659879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiograms in patients with ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and Takotsubo syndrome.
    Madias JE
    Int J Cardiol; 2015 Dec; 201():60. PubMed ID: 26298347
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum amyloid A protein in very low density--and high density lipoproteins during the course of acute myocardial infarction.
    Feussner G; Schuster M; Ziegler R
    Electrophoresis; 1991 Apr; 12(4):283-6. PubMed ID: 2070782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
    Généreux P; Madhavan MV; Mintz GS; Maehara A; Palmerini T; Lasalle L; Xu K; McAndrew T; Kirtane A; Lansky AJ; Brener SJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2014 May; 63(18):1845-54. PubMed ID: 24561145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
    Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
    Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.
    Dandona P; Chaudhuri A; Ghanim H; Mohanty P
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S25-34. PubMed ID: 17224874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.
    Gaziano JM; Hennekens CH; O'Donnell CJ; Breslow JL; Buring JE
    Circulation; 1997 Oct; 96(8):2520-5. PubMed ID: 9355888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HDL-cholesterol in coronary disease in the acute phase].
    Abrate M; Pizzuti A; Bernardi F; Bulgarelli G; Aillon C; Passarino G; Della Beffa V; Carta Q; Angelino PF
    Boll Soc Ital Cardiol; 1981; 26(11):1823-5. PubMed ID: 7349248
    [No Abstract]   [Full Text] [Related]  

  • 33. Dyslipidaemia: Apo-AI infusion after acute MI.
    Lim GB
    Nat Rev Cardiol; 2017 Jan; 14(1):6. PubMed ID: 27883006
    [No Abstract]   [Full Text] [Related]  

  • 34. Alterations in plasma proteins and lipoproteins in acute myocardial infarction: effects on activation of lipoprotein lipase.
    Stubbe I; Gustafson A; Nilsson-Ehle P
    Scand J Clin Lab Invest; 1982 Sep; 42(5):437-44. PubMed ID: 7156856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variations in the composition of low- and high-density lipoproteins during the acute phase of myocardial infarction.
    Mainard F; Madec Y; Robinet N
    Clin Chem; 1988 Jan; 34(1):139-40. PubMed ID: 3338144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reconstituted HDL in acute coronary syndromes.
    Chenevard R; Hürlimann D; Spieker L; Béchir M; Enseleit F; Hermann M; Flammer AJ; Sudano I; Corti R; Lüscher TF; Noll G; Ruschitzka F
    Cardiovasc Ther; 2012 Apr; 30(2):e51-7. PubMed ID: 20840194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of hyperglycaemia on morbidity and mortality of acute coronary syndromes and acute myocardial infarction.
    Sahibzada P; Khan AA; Sahibzada WA
    J Ayub Med Coll Abbottabad; 2009; 21(1):110-5. PubMed ID: 20364756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.
    Pache J; Kastrati A; Mehilli J; Bollwein H; Ndrepepa G; Schühlen H; Martinoff S; Seyfarth M; Nekolla S; Dirschinger J; Schwaiger M; Schömig A
    Am Heart J; 2004 Jul; 148(1):e3. PubMed ID: 15215812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different clinical and coronary angiographic findings according to ratios of total cholesterol to high-density lipoprotein cholesterol during the acute phase of myocardial infarction.
    Kosuge M; Kimura K; Ishikawa T; Shimizu T; Sugano T; Sumita S; Hibi K; Takamura T; Toda N; Kanna M; Tsukahara K; Okuda J; Tahara Y; Nozawa N; Furukawa E; Umemura S
    J Cardiol; 2004 Jun; 43(6):251-8. PubMed ID: 15242074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute coronary syndromes: Complete revascularization for STEMI.
    Adams L
    Nat Rev Cardiol; 2017 Apr; 14(5):254-255. PubMed ID: 28397848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.